NR3B inhibitors belong to a distinct chemical class characterized by their capacity to modulate specific molecular targets within cellular systems. These inhibitors interact with NR3B receptors, a subset of nuclear receptors that play essential roles in various physiological processes. NR3B inhibitors exert their effects by binding to these receptors, thereby altering their activity and downstream signaling pathways. The intricate interplay between NR3B receptors and their associated molecules makes NR3B inhibitors valuable tools for researchers seeking to dissect the intricate regulatory networks that govern cellular function.
These inhibitors are designed through meticulous synthetic routes, resulting in compounds with the structural features necessary for effective binding to NR3B receptors. Their mechanism of action involves precise molecular recognition, influencing the conformational changes that impact the receptor's functional output. The study of NR3B inhibitors provides invaluable insights into the fundamental mechanisms that underlie cellular processes and contributes to the advancement of scientific knowledge in the field of molecular biology and biochemistry.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK 4716 | 101574-65-6 | sc-203986 sc-203986A | 10 mg 50 mg | $71.00 $285.00 | ||
GSK4716 is an ERRγ agonist that has been used to study the effects of ERRγ activation on metabolism and other cellular processes. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GSK516 is an ERRγ antagonist that has been investigated for its potential to modulate glucose and lipid metabolism. | ||||||
SR 1001 | 1335106-03-0 | sc-507320 | 5 mg | $150.00 | ||
SR1001 is a synthetic compound that acts as an inverse agonist of ERRγ and has been studied for its role in metabolism regulation. | ||||||